Lipid profile study in Noonan syndrome and related disorders
Part of Bones, joints & muscles, Genetic & congenital, Heart & circulation, Skin clinical trials.
This study looks at cholesterol and fat levels in people with Noonan syndrome or related conditions. It aims to understand how these levels change with age, gender, and genetic cause.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of Noonan syndrome or a related condition (RASopathy) through genetic testing.
- You were first seen at a participating center between 2001 and 2022.
- You are between 2 and 35 years old now.
- You or your guardian must agree to join the study by signing a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people who have a RASopathy—a genetic condition—and also have solid tumors (tumor growths not in blood). To join, your RASopathy must be confirmed by genetic testing, not only by symptoms.
This study collects and stores health samples and information from people with RASopathy conditions (like Noonan or Costello syndromes) and from family members who may not have the condition. It helps researchers understand these disorders and supports future studies that could lead to better care.
This study collects biological samples to better understand what causes Noonan syndrome. If you qualify, your participation could help researchers learn how the condition works and guide future care.
This study looks at people with certain inherited genetic conditions called RASopathies and their family members. It helps researchers understand these conditions and how genetic changes run in families, which may improve future care.
This study looks at whether people with Noonan syndrome have unusual bleeding or blood clotting problems. It aims to better understand these issues so doctors can offer better care.
This trial is a real-world registry that collects information about children with Noonan syndrome who are treated with Norditropin (a growth hormone). It helps researchers understand how these children do over time in routine care.
Hear when a new Noonan Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.